AF
HOOK

Amalgamated Financial’s HOOKIPA Pharma HOOK Stock Holding History

Amalgamated Financial’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$6K Buy
+285
New +$5.11K ﹤0.01% 2952

Other funds holding HOOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Amalgamated Financial's HOOK Position: Q1 2022 in Review

Amalgamated Financial opened a new position in HOOKIPA Pharma (HOOK) in Q1 2022: 285 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #2952 among its holdings.

74 funds tracked by Wall St. Rank hold HOOK as of Q1 2022.

  • Amalgamated Financial held 285 shares of HOOKIPA Pharma worth $6K as of Q1 2022.
  • HOOKIPA Pharma was a new Amalgamated Financial position in Q1 2022.
  • HOOKIPA Pharma made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2952 holding.
  • 74 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.